The buying is entirely mega-passive, reflecting index rebalancing rather than active conviction. Monitor for active fund interest (e.g., healthcare-specialist hedge funds or biotech-focused funds) as a stronger signal.
VOR drugs
VOR drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $14.09entry
- T+1 · 5mo ago +1.92%α +1.38% · $14.36
- T+5 · 5mo ago +6.60%α +6.17% · $15.02
- T+20 · 4mo ago +40.17%α +38.28% · $19.75
- T+60 · 2mo ago +77.79%α +73.39% · $25.05
How similar events traded
Executive Summary
Five mega-passive institutional investors (Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley) collectively more than doubled their VOR positions in Q4 2025, adding $31.8M in new holdings to reach $50.8M total. This is an index-driven rebalancing move, likely reflecting VOR's continued inclusion in growth/small-cap passive mandates, not an active conviction thesis.
Key Financial Metrics
Institutional Positions
Net institutional flow: $31.8M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Vanguard | DOUBLED | +632.2% | $10.1M | $5.0M |
| BlackRock | DOUBLED | +1248.5% | $6.1M | $4.4M |
| State Street | DOUBLED | +905.7% | $1.2M | $750.0K |
| Fidelity | DOUBLED | +968.1% | $33.0M | $21.5M |
| Morgan Stanley | DOUBLED | +538.8% | $372.0K | $155.0K |
Key Facts
- 5 institutions accumulated $31.8M net in VOR during Q4 2025, bringing aggregate holdings to $50.8M
- Every buyer was a mega-passive fund: Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley
- All five funds DOUBLED or more their positions (range: +539% to +1249% share increases)
- Zero institutional sellers detected in this cluster
Financial Impact
5 institutions accumulated $31.8M in new VOR holdings, increasing total disclosed institutional position value from $19.0M to $50.8M
Risk Factors
- No active or catalyst-driven buyers, all accumulation is passive/index rebalancing, which carries weaker predictive signal
- 13F data is stale (45-day lag); positions may have already been unwound or adjusted
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-VOR-2025-Q4 |
Track record
17 reports on VOR
3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +70.35% at T+60 after the Jun 8, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $18.97 settles Nov 18
- Nov 12, 20264d ago 8-K Neutral 5/10 Entry $19.32 to $19.42 ▲ +0.52% +0.88% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $18.66 to $19.88 ▲ +6.54% +6.23% vs SPY
- Oct 30, 202617d ago 424B5 Bearish 4/10 Entry $19.68 to $19.25 ▲ +2.19% +1.71% vs SPY
- Oct 30, 202617d ago Press Release Neutral 4/10 Entry $19.68 to $19.25 ▼ −2.19% −1.71% vs SPY
- Oct 22, 202625d ago Press Release Bullish 7/10 Entry $18.26 to $18.33 ▲ +0.38% −0.33% vs SPY
- Oct 5, 20266w ago Press Release Neutral 2/10 Entry $18.31 to $18.78 ▲ +2.57% +2.81% vs SPY
- Sep 29, 20266w ago Press Release Bullish 6/10 Entry $18.33 to $19.08 ▲ +4.09% +4.30% vs SPY
- Aug 11, 202613w ago Press Release Neutral 3/10 Entry $23.37 to $22.34 ▼ −4.41% −4.66% vs SPY
- Jul 9, 202618w ago 3 Neutral 2/10 Entry $19.14 to $18.03 ▼ −5.80% −5.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers